GG 1978

Solarea Bio, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing microbial therapeutics to address health disorders linked to chronic inflammation. Founded in 2017, the company utilizes a platform that combines microbial discovery and genomics to create synergistic microbial assemblages using bacteria and fungi derived from healthy foods. Solarea Bio generates an extensive database of complete genomic sequences of these microbes and employs computational approaches to formulate combinations that exhibit strong anti-inflammatory properties. The company's therapeutics aim to prevent or mitigate health issues associated with chronic inflammation, with initial applications targeting dietary management of metabolic conditions like osteopenia and osteoporosis in postmenopausal women. Through its innovative approach, Solarea Bio seeks to enhance the quality of life by providing nature-based solutions for various health challenges.